"iHALT unlocks liver functionality as a surrogate secondary lymphoid organ"

Dr. John Gridley is a viral immunologist whose research primarily focuses on determining how antigens of various anatomical confinement patterns uniquely instruct the quality and spatiotemporal dynamics of ensuing adaptive immune responses. John obtained his Pharm.D. from Samford University McWhorter School of Pharmacy, where he developed a strong interest in research working with Dr. Robert Wang in the investigation of small molecule correctors for cystic fibrosis. Seeking to pursue research full-time, John began his postdoctoral training at Emory University in the laboratory of Dr. Arash Grakoui. Here, he has since contributed to the characterization of the correlates of protective immunity during hepatitis C virus (HCV)-related rodent hepacivirus infection, elucidated the potential of the liver to function as a surrogate secondary lymphoid organ, and contributed to the design of HCV vaccine candidates. During his postdoctoral training, John was supported by the Emory Vaccinology Training Program (T32, 2023-2024) and is currently supported by an NIH NRSA individual postdoctoral fellowship grant (NIAID F32, 2024-present).